The AMP-activated protein kinase cascade - A unifying system for energy control

Trends in Biochemical Sciences

Volumn 29, Issue 1, 2004, Pages 18-24

  Carling, David ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(HYDROXYMETHYLGLUTARYL COA REDUCTASE (NADPH)) KINASE; (HYDROXYMETHYLGLUTARYL-COA REDUCTASE (NADPH)) KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; MULTIENZYME COMPLEX; PROTEIN KINASE; PROTEIN KINASE LKB1; PROTEIN SERINE THREONINE KINASE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL; CHEMISTRY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; ENZYME SUBUNIT; FAMILIAL CANCER; GENE MUTATION; GENETIC CONSERVATION; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; METABOLIC DISORDER; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSMOTIC STRESS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; WOLFF PARKINSON WHITE SYNDROME;

ANIMALIA;

EID: 0347318052     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2003.11.005     Document Type: Review

References (62)

1. Hardie D.G., et al. The AMP-activated protein kinase-a multisubstrate regulator of lipid metabolism. Trends Biochem. Sci. 14:1989;20-23.
2. Hardie D.G., Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell. Eur. J. Biochem. 246:1997;259-273.
3. Hardie D.G., et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67:1998;821-855.
4. Hardie D.G., et al. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546:2003;113-120.
5. Corton J.M., et al. Role of the AMP-activated protein kinase in the cellular stress response. Curr. Biol. 4:1994;315-324.
6. Kemp B.E., et al. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem. Sci. 24:1999;22-25.
7. Foretz M., et al. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273:1998;14767-14771.
8. Leclerc I., et al. The AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 431:1998;180-184.
9. Yang W., et al. Regulation of transcription by AMP-activated protein kinase. J. Biol. Chem. 276:2001;38341-38344.
10. Winder W., et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88:2000;2219-2226.
11. Fryer L.G.D., et al. Characterisation of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle. Biochem. J. 363:2002;167-174.
12. Fryer L.G.D., et al. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct pathways. J. Biol. Chem. 277:2002;25226-25232.
13. Hawley S.A., et al. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes. 51:2002;2420-2425.
14. Merrill G.F., et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273:1997;E1107-E1112.
15. Hayashi T., et al. Evidence for AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes. 47:1998;1369-1373.
16. Mu J., et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell. 7:2001;1085-1094.
17. Ahima R.S., Flier J.S. Leptin. Annu. Rev. Physiol. 62:2000;413-437.
18. Yamauchi T., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:2001;941-946.
19. Minokoshi Y., et al. Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase. Nature. 415:2002;339-343.
20. Yamauchi T., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:2002;1288-1295.
21. Rutter G.A., et al. Roles of 5′AMP-activated protein kinase in mammalian glucose homeostasis. Biochem. J. 375:2003;1-16.
22. Viollet B., et al. The AMP-activated protein kinase α2 catalytic subunit controls whole body insulin sensitivity. J. Clin. Invest. 111:2003;91-98.
23. Carlson M. Glucose repression in yeast. Curr. Opin. Microbiol. 2:1999;202-207.
24. Hanks S.K., et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 241:1988;42-52.
25. Crute B.E., et al. Functional domains of the α1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273:1998;35347-35354.
26. Woods A., et al. Characterization of AMP-activated protein kinase β subunit and γ subunit - assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271:1996;10282-10290.
27. Hudson E.R., et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13:2003;861-866.
28. Polekhina G., et al. AMPK β subunit targets metabolic stress sensing to glycogen. Curr. Biol. 13:2003;867-871.
29. Carling D., Hardie D.G. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim. Biophys. Acta. 1012:1989;81-86.
30. Wojtaszewski J.F.P., et al. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes. 51:2002;284-292.
31. Bateman A. The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem. Sci. 22:1997;12-13.
32. Cheung P.C.F., et al. Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem. J. 346:2000;659-669.
33. Andersson L. Identification and characterization of AMPK γ3 mutations in the pig. Biochem. Soc. Trans. 31:2003;232-235.
34. Milan D., et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science. 288:2000;1248-1251.
35. Blair E., et al. Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10:2001;1215-1220.
36. Gollob M.H., et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344:2001;1823-1831.
37. Gollob M.H., et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. 104:2001;3030-3033.
38. Arad M., et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest. 109:2002;357-362.
39. Lang T., et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant γ2 subunit of 5′-AMP-activated protein kinase, to chromosome 7q36. Genomics. 70:2000;258-263.
40. Daniel T., Carling D. Functional analysis of mutations in the γ2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277:2002;51017-51024.
41. Arad M., et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation. 107:2003;2850-2856.
42. Hawley S.A., et al. Characterisation of the AMP-activated protein kinase kinase from rat liver and identification of threonine-172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271:1996;27879-27887.
43. Johnson L.N., et al. Active and inactive protein kinases: structural basis for regulation. Cell. 85:1996;149-158.
44. Woods A., et al. Identification of phosphorylation sites in AMP-activated protein kinase for upstream AMP-activated protein kinase kinases and study of their roles by site-directed mutagenesis. J. Biol. Chem. 278:2003;28434-28442.
45. Stein S.C., et al. The regulation of AMP-activated protein kinase phosphorylation. Biochem. J. 345:2000;437-443.
46. Kovacic S., et al. Akt activity negatively regulates phosphorylation of AMPK in the heart. J. Biol. Chem. 278:2003;39422-39427.
47. Beauloye C., et al. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett. 505:2001;348-352.
48. Hong S.P., et al. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. U. S. A. 100:2003;8839-8843.
49. Sutherland C.M., et al. Elm1p is one of three upstream kinases for the Saccharomyces cerevisiae SNF1 complex. Curr. Biol. 13:2003;1299-1305.
50. Nath N., et al. Yeast Pak1 kinase associates with and activates Snf1. Mol. Cell. Biol. 23:2003;3909-3917.
51. 2+/calmodulin activates the calmodulin- dependent protein kinase-I cascade, via 3 independent mechanisms. J. Biol. Chem. 270:1995;27186-27191.
52. Hemminki A., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:1998;184-187.
53. Jenne D.E., et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18:1998;38-43.
54. Hawley S.A., et al. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2:2003;28.
55. Woods A., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13:2003;2004-2008.
56. Wang W., et al. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 278:2003;27016-27023.
57. Mitchelhill K.I., et al. Post-translational modifications of the 5′-AMP-activated protein kinase β1 subunit. J. Biol. Chem. 272:1997;24475-24479.
58. Mitchelhill K.I., et al. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269:1994;2361-2364.
59. Carling D., et al. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem. 269:1994;11442-11448.
60. Stapleton D., et al. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271:1996;611-614.
61. Dyck J.R.B., et al. Regulation of AMP-activated protein kinase activity by the noncatalytic β and γ subunits. J. Biol. Chem. 271:1996;17798-17803.
62. Thornton C., et al. Identification of a novel AMP-activated protein kinase β isoform which is highly expressed in skeletal muscle. J. Biol. Chem. 273:1998;12443-12450.